Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou1f1
|
ENSMUSG00000004842.12 | POU domain, class 1, transcription factor 1 |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_157242024_157242632 | 16.27 |
Rasal2 |
RAS protein activator like 2 |
2162 |
0.36 |
chr11_54596874_54597434 | 15.64 |
Rapgef6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
980 |
0.6 |
chr13_84063384_84064052 | 15.38 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr12_31711839_31712627 | 13.56 |
Gpr22 |
G protein-coupled receptor 22 |
1693 |
0.32 |
chr2_181767278_181768191 | 13.49 |
Myt1 |
myelin transcription factor 1 |
222 |
0.91 |
chr18_31445092_31445474 | 13.14 |
Syt4 |
synaptotagmin IV |
2123 |
0.26 |
chr2_158606690_158608449 | 12.96 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr12_72234504_72235243 | 12.93 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr1_81077232_81078427 | 12.44 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr2_65565600_65566271 | 12.23 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr1_143643975_143644626 | 11.28 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
1775 |
0.33 |
chr2_6883618_6884699 | 10.58 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chrX_165325643_165325925 | 10.39 |
Glra2 |
glycine receptor, alpha 2 subunit |
1609 |
0.56 |
chr2_22625054_22625976 | 10.00 |
Gad2 |
glutamic acid decarboxylase 2 |
2211 |
0.22 |
chr4_36947337_36947887 | 9.88 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
2855 |
0.31 |
chr3_17782537_17782894 | 9.87 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
7206 |
0.19 |
chr16_81201314_81201888 | 9.77 |
Ncam2 |
neural cell adhesion molecule 2 |
844 |
0.72 |
chr16_77594640_77595970 | 9.71 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr13_8205494_8206737 | 9.70 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chr10_49785211_49786117 | 9.68 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2255 |
0.25 |
chr16_77646908_77647363 | 9.53 |
C130023A14Rik |
RIKEN cDNA C130023A14 gene |
795 |
0.35 |
chr1_66323058_66323271 | 9.52 |
Map2 |
microtubule-associated protein 2 |
1062 |
0.51 |
chr1_143643096_143643376 | 9.51 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
711 |
0.65 |
chr12_38784801_38785131 | 9.43 |
Etv1 |
ets variant 1 |
1457 |
0.46 |
chr5_103209022_103210413 | 9.35 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr4_116405618_116406369 | 9.31 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr15_22549492_22550147 | 9.27 |
Cdh18 |
cadherin 18 |
797 |
0.78 |
chr6_136170568_136170996 | 9.06 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1107 |
0.5 |
chr2_82056608_82056868 | 9.01 |
Zfp804a |
zinc finger protein 804A |
3516 |
0.36 |
chr1_143640264_143641520 | 8.96 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr5_84413029_84413589 | 8.95 |
Epha5 |
Eph receptor A5 |
3497 |
0.31 |
chr3_76075315_76075943 | 8.89 |
Fstl5 |
follistatin-like 5 |
46 |
0.98 |
chr1_32173438_32173903 | 8.85 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
783 |
0.74 |
chr3_17799177_17799545 | 8.78 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
3617 |
0.21 |
chr2_107292125_107293014 | 8.76 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
1174 |
0.64 |
chr15_26310303_26310668 | 8.75 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
1421 |
0.58 |
chr15_77151074_77151695 | 8.73 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
2172 |
0.24 |
chr11_57011668_57012922 | 8.65 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
339 |
0.94 |
chr3_4799014_4799414 | 8.62 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
279 |
0.93 |
chr8_109245493_109246323 | 8.62 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr13_105248515_105248922 | 8.52 |
Rnf180 |
ring finger protein 180 |
22321 |
0.21 |
chr6_55680133_55680881 | 8.28 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr4_5724213_5725550 | 8.21 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chrX_103185161_103185695 | 8.18 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
1212 |
0.36 |
chr4_102590727_102591712 | 8.15 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1376 |
0.58 |
chr4_78209143_78209724 | 7.97 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
2306 |
0.29 |
chr12_31712818_31713098 | 7.92 |
Gpr22 |
G protein-coupled receptor 22 |
968 |
0.51 |
chr7_61311164_61311772 | 7.89 |
A230006K03Rik |
RIKEN cDNA A230006K03 gene |
245 |
0.96 |
chr13_109442519_109443753 | 7.82 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr3_56179928_56180616 | 7.82 |
Nbea |
neurobeachin |
3429 |
0.25 |
chr3_107039197_107039974 | 7.76 |
AI504432 |
expressed sequence AI504432 |
81 |
0.96 |
chr2_6881874_6882908 | 7.70 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr8_41052368_41053980 | 7.68 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chrX_88112223_88112880 | 7.64 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
3094 |
0.35 |
chr8_54956010_54956394 | 7.62 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chr7_99270744_99271357 | 7.57 |
Map6 |
microtubule-associated protein 6 |
1918 |
0.23 |
chr3_84953332_84953942 | 7.51 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
1491 |
0.53 |
chr15_78118661_78118936 | 7.41 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
908 |
0.42 |
chr17_91086370_91086959 | 7.36 |
Gm47307 |
predicted gene, 47307 |
1742 |
0.26 |
chr5_15937662_15938665 | 7.35 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
3252 |
0.2 |
chr7_128689996_128690220 | 7.35 |
Gm43580 |
predicted gene 43580 |
1573 |
0.19 |
chr3_80799469_80799764 | 7.34 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
2963 |
0.34 |
chr3_34653590_34654523 | 7.33 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chr13_109443973_109444887 | 7.32 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
2247 |
0.46 |
chr3_80796675_80796826 | 7.32 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
5829 |
0.28 |
chr14_88465511_88465662 | 7.32 |
Pcdh20 |
protocadherin 20 |
5760 |
0.24 |
chr13_83739310_83740387 | 7.29 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr18_43686213_43686392 | 7.28 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
1323 |
0.49 |
chr18_64890376_64890890 | 7.21 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
140 |
0.95 |
chr8_109248088_109248728 | 7.20 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1458 |
0.54 |
chr1_70726785_70727115 | 7.20 |
Vwc2l |
von Willebrand factor C domain-containing protein 2-like |
1027 |
0.69 |
chr2_34358720_34358871 | 7.19 |
Pbx3 |
pre B cell leukemia homeobox 3 |
12051 |
0.19 |
chr17_90452047_90452824 | 7.18 |
Nrxn1 |
neurexin I |
2387 |
0.31 |
chr10_57787071_57787893 | 7.17 |
Fabp7 |
fatty acid binding protein 7, brain |
2559 |
0.25 |
chr13_109928298_109928867 | 7.16 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1738 |
0.46 |
chr1_24869771_24870242 | 7.16 |
Gm28594 |
predicted gene 28594 |
41653 |
0.16 |
chr3_13946382_13947629 | 7.15 |
Ralyl |
RALY RNA binding protein-like |
594 |
0.84 |
chr3_4796861_4798079 | 7.15 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr10_29145199_29145467 | 7.14 |
Gm9996 |
predicted gene 9996 |
1139 |
0.36 |
chrX_23282702_23282891 | 7.12 |
Klhl13 |
kelch-like 13 |
2033 |
0.45 |
chr7_60939270_60939914 | 7.02 |
Gm44644 |
predicted gene 44644 |
16682 |
0.22 |
chr7_128690432_128691249 | 6.99 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr11_32001099_32002296 | 6.98 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr13_83728524_83729044 | 6.97 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
678 |
0.43 |
chr9_4791870_4792180 | 6.97 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
3494 |
0.38 |
chr7_62366195_62366527 | 6.94 |
Magel2 |
melanoma antigen, family L, 2 |
10649 |
0.18 |
chr15_77244882_77245075 | 6.87 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
528 |
0.72 |
chr5_88583326_88583955 | 6.86 |
Rufy3 |
RUN and FYVE domain containing 3 |
62 |
0.97 |
chr9_113813101_113813610 | 6.83 |
Clasp2 |
CLIP associating protein 2 |
755 |
0.71 |
chr7_51623529_51624502 | 6.83 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr1_157243489_157244692 | 6.81 |
Rasal2 |
RAS protein activator like 2 |
400 |
0.88 |
chr16_43507761_43509014 | 6.76 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
124 |
0.97 |
chr12_29536127_29536438 | 6.76 |
Myt1l |
myelin transcription factor 1-like |
1060 |
0.47 |
chrX_152643367_152644550 | 6.72 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr3_16818309_16818538 | 6.69 |
Gm26485 |
predicted gene, 26485 |
4889 |
0.36 |
chr4_110280147_110280809 | 6.68 |
Elavl4 |
ELAV like RNA binding protein 4 |
6138 |
0.32 |
chr4_13754294_13755025 | 6.67 |
Runx1t1 |
RUNX1 translocation partner 1 |
3362 |
0.37 |
chr1_165934491_165935029 | 6.63 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
140 |
0.95 |
chr4_24429901_24430719 | 6.56 |
Gm27243 |
predicted gene 27243 |
580 |
0.79 |
chr1_155414821_155416000 | 6.51 |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
1919 |
0.42 |
chr16_77418527_77418853 | 6.48 |
Gm38071 |
predicted gene, 38071 |
2066 |
0.19 |
chr5_70841090_70841579 | 6.43 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
870 |
0.75 |
chr2_77701567_77703605 | 6.42 |
Zfp385b |
zinc finger protein 385B |
686 |
0.8 |
chr13_83528752_83528983 | 6.41 |
Mef2c |
myocyte enhancer factor 2C |
1271 |
0.6 |
chr2_6869935_6870654 | 6.40 |
Celf2 |
CUGBP, Elav-like family member 2 |
1678 |
0.39 |
chr12_29528407_29529244 | 6.37 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr8_112572299_112572848 | 6.37 |
Cntnap4 |
contactin associated protein-like 4 |
2518 |
0.32 |
chr8_65619789_65620230 | 6.37 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
1484 |
0.52 |
chr2_65620767_65621991 | 6.36 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr3_17790851_17791260 | 6.36 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1098 |
0.49 |
chr5_131531462_131532675 | 6.33 |
Auts2 |
autism susceptibility candidate 2 |
2329 |
0.29 |
chr11_41999400_42000640 | 6.32 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr18_35212708_35213458 | 6.32 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr2_97471929_97472576 | 6.32 |
Lrrc4c |
leucine rich repeat containing 4C |
4163 |
0.36 |
chr5_116588938_116589443 | 6.31 |
Srrm4 |
serine/arginine repetitive matrix 4 |
2627 |
0.26 |
chr3_88208985_88210116 | 6.30 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr8_33747278_33748028 | 6.30 |
Smim18 |
small integral membrane protein 18 |
117 |
0.95 |
chr5_90339159_90340201 | 6.24 |
Ankrd17 |
ankyrin repeat domain 17 |
63 |
0.98 |
chr16_67618113_67618498 | 6.23 |
Cadm2 |
cell adhesion molecule 2 |
2188 |
0.39 |
chr2_97470615_97471412 | 6.22 |
Lrrc4c |
leucine rich repeat containing 4C |
2924 |
0.4 |
chr16_41534559_41535426 | 6.20 |
Lsamp |
limbic system-associated membrane protein |
1573 |
0.55 |
chr5_111424407_111425623 | 6.20 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr18_35210523_35210985 | 6.20 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
4176 |
0.2 |
chr12_89815493_89816199 | 6.17 |
Nrxn3 |
neurexin III |
3363 |
0.39 |
chrX_88113433_88114223 | 6.16 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
1817 |
0.46 |
chr10_109008310_109009456 | 6.16 |
Syt1 |
synaptotagmin I |
217 |
0.96 |
chr19_47017426_47018238 | 6.12 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2679 |
0.17 |
chr11_94045498_94046076 | 6.08 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr12_41483283_41485192 | 6.08 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr4_82509049_82510307 | 6.07 |
Gm11266 |
predicted gene 11266 |
1662 |
0.38 |
chr4_82494042_82494837 | 6.06 |
Nfib |
nuclear factor I/B |
4877 |
0.23 |
chr7_62366760_62367184 | 6.02 |
Magel2 |
melanoma antigen, family L, 2 |
10038 |
0.18 |
chr10_90578974_90579573 | 5.85 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
2281 |
0.42 |
chr12_46814495_46815083 | 5.85 |
Nova1 |
NOVA alternative splicing regulator 1 |
2171 |
0.31 |
chr12_88723574_88724074 | 5.79 |
Nrxn3 |
neurexin III |
715 |
0.73 |
chr16_77240922_77241478 | 5.78 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
4881 |
0.26 |
chr13_83737592_83739114 | 5.77 |
Gm33366 |
predicted gene, 33366 |
182 |
0.66 |
chr12_29529828_29531185 | 5.76 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr7_73554834_73555113 | 5.75 |
1810026B05Rik |
RIKEN cDNA 1810026B05 gene |
947 |
0.42 |
chr5_111422795_111423499 | 5.74 |
Gm43119 |
predicted gene 43119 |
442 |
0.8 |
chr3_56181373_56181654 | 5.74 |
Nbea |
neurobeachin |
2188 |
0.32 |
chr1_115686481_115687365 | 5.72 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chrX_134406275_134406692 | 5.71 |
Drp2 |
dystrophin related protein 2 |
1681 |
0.35 |
chr9_89737616_89738628 | 5.69 |
Ankrd34c |
ankyrin repeat domain 34C |
323 |
0.86 |
chr6_17749231_17750103 | 5.69 |
St7 |
suppression of tumorigenicity 7 |
275 |
0.78 |
chr4_97780769_97781308 | 5.67 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
2960 |
0.25 |
chr1_168676421_168677250 | 5.67 |
1700063I16Rik |
RIKEN cDNA 1700063I16 gene |
953 |
0.73 |
chr1_99774315_99774575 | 5.66 |
Cntnap5b |
contactin associated protein-like 5B |
1680 |
0.43 |
chr11_108607202_108607707 | 5.65 |
Cep112 |
centrosomal protein 112 |
2227 |
0.37 |
chr13_83734808_83735118 | 5.64 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2397 |
0.18 |
chr8_109250241_109250821 | 5.62 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
665 |
0.8 |
chr1_25832036_25832712 | 5.61 |
Gm9884 |
predicted gene 9884 |
1717 |
0.22 |
chr5_20228356_20229007 | 5.60 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
495 |
0.83 |
chr19_24453309_24453833 | 5.59 |
Fam122a |
family with sequence similarity 122, member A |
23785 |
0.19 |
chr2_138277835_138280637 | 5.57 |
Btbd3 |
BTB (POZ) domain containing 3 |
743 |
0.81 |
chr7_61595057_61595589 | 5.55 |
B230209E15Rik |
RIKEN cDNA B230209E15 gene |
20004 |
0.15 |
chr6_136171003_136171483 | 5.53 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
646 |
0.69 |
chr16_81203792_81204456 | 5.53 |
Ncam2 |
neural cell adhesion molecule 2 |
3367 |
0.33 |
chr2_136715590_136716138 | 5.52 |
Snap25 |
synaptosomal-associated protein 25 |
2386 |
0.31 |
chr1_66388178_66389004 | 5.51 |
Map2 |
microtubule-associated protein 2 |
1580 |
0.42 |
chr3_4798346_4798833 | 5.51 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
119 |
0.97 |
chrX_166348094_166348432 | 5.49 |
Gpm6b |
glycoprotein m6b |
3421 |
0.29 |
chr3_110141027_110141408 | 5.48 |
Ntng1 |
netrin G1 |
1787 |
0.46 |
chr6_136167149_136168437 | 5.47 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
4096 |
0.25 |
chr3_18057619_18058479 | 5.46 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
3875 |
0.23 |
chr3_8509825_8511666 | 5.45 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr8_61515455_61516269 | 5.45 |
Palld |
palladin, cytoskeletal associated protein |
38 |
0.98 |
chr18_6514668_6515014 | 5.45 |
Epc1 |
enhancer of polycomb homolog 1 |
1267 |
0.42 |
chr13_83727321_83728283 | 5.44 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
304 |
0.83 |
chr1_9295695_9295976 | 5.41 |
Sntg1 |
syntrophin, gamma 1 |
2401 |
0.27 |
chr9_43070934_43071231 | 5.40 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
28450 |
0.16 |
chr4_22484307_22484937 | 5.39 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
3744 |
0.2 |
chr13_34126566_34127191 | 5.39 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr7_61309776_61310205 | 5.38 |
A230006K03Rik |
RIKEN cDNA A230006K03 gene |
1723 |
0.5 |
chr14_61600038_61600691 | 5.38 |
Trim13 |
tripartite motif-containing 13 |
824 |
0.41 |
chr16_77598670_77599917 | 5.36 |
Mir99a |
microRNA 99a |
357 |
0.44 |
chr9_96731522_96733329 | 5.36 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chr16_43504464_43505047 | 5.35 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr9_42121573_42122781 | 5.34 |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
2120 |
0.33 |
chr1_25828771_25829000 | 5.33 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
626 |
0.54 |
chr14_60382521_60383103 | 5.31 |
Amer2 |
APC membrane recruitment 2 |
4526 |
0.25 |
chr3_88216674_88217001 | 5.31 |
Gm25641 |
predicted gene, 25641 |
1141 |
0.2 |
chrX_6169933_6171264 | 5.30 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
2417 |
0.31 |
chr16_74408614_74409150 | 5.30 |
Robo2 |
roundabout guidance receptor 2 |
2030 |
0.43 |
chr12_31711352_31711698 | 5.29 |
Gpr22 |
G protein-coupled receptor 22 |
2401 |
0.25 |
chr9_60686843_60686994 | 5.27 |
Lrrc49 |
leucine rich repeat containing 49 |
616 |
0.74 |
chr4_13753841_13754203 | 5.27 |
Runx1t1 |
RUNX1 translocation partner 1 |
2725 |
0.4 |
chr6_77246252_77246852 | 5.26 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
3630 |
0.32 |
chr12_29537800_29538885 | 5.26 |
Myt1l |
myelin transcription factor 1-like |
3120 |
0.28 |
chr10_110453550_110454045 | 5.26 |
Nav3 |
neuron navigator 3 |
2407 |
0.34 |
chr4_25797578_25797990 | 5.26 |
Fut9 |
fucosyltransferase 9 |
2071 |
0.32 |
chr13_20473087_20474265 | 5.25 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr5_57723598_57724600 | 5.24 |
Gm42635 |
predicted gene 42635 |
294 |
0.83 |
chr12_15811126_15812067 | 5.22 |
Trib2 |
tribbles pseudokinase 2 |
5189 |
0.17 |
chr13_83724319_83724624 | 5.22 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3090 |
0.17 |
chr12_29531656_29532106 | 5.22 |
Gm20208 |
predicted gene, 20208 |
766 |
0.61 |
chr1_158354059_158354432 | 5.19 |
Brinp2 |
bone morphogenic protein/retinoic acid inducible neural-specific 2 |
1984 |
0.33 |
chr2_152086279_152087493 | 5.19 |
Scrt2 |
scratch family zinc finger 2 |
5357 |
0.15 |
chr16_77647533_77647722 | 5.18 |
C130023A14Rik |
RIKEN cDNA C130023A14 gene |
1287 |
0.25 |
chrX_166346283_166346827 | 5.18 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.6 | 28.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
8.2 | 24.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.5 | 5.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
3.9 | 11.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.8 | 11.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
3.7 | 14.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
3.6 | 10.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.5 | 14.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.4 | 10.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
3.2 | 9.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
3.0 | 11.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.9 | 26.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
2.9 | 20.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.8 | 19.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.8 | 8.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.7 | 24.6 | GO:0071625 | vocalization behavior(GO:0071625) |
2.6 | 12.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
2.5 | 10.0 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
2.5 | 7.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.5 | 27.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.4 | 7.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
2.4 | 7.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.3 | 6.9 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.3 | 16.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.3 | 6.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.2 | 13.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.2 | 6.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.2 | 4.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.2 | 28.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.2 | 6.6 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
2.1 | 20.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
2.1 | 4.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.0 | 8.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.9 | 11.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.9 | 1.9 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.9 | 9.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.9 | 9.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.8 | 12.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.8 | 3.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.8 | 16.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.8 | 7.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.7 | 17.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.7 | 6.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.7 | 6.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.7 | 1.7 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.7 | 8.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.6 | 12.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.6 | 6.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.6 | 1.6 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.6 | 9.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.6 | 12.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.5 | 12.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.5 | 12.2 | GO:0060074 | synapse maturation(GO:0060074) |
1.5 | 6.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.5 | 4.5 | GO:0007525 | somatic muscle development(GO:0007525) |
1.5 | 25.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.5 | 7.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.5 | 4.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.4 | 14.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.4 | 11.5 | GO:0050957 | equilibrioception(GO:0050957) |
1.4 | 1.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.4 | 9.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.4 | 12.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.4 | 4.2 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.4 | 4.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.4 | 9.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.3 | 2.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.3 | 6.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.3 | 11.3 | GO:0060539 | diaphragm development(GO:0060539) |
1.2 | 3.7 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.2 | 7.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.2 | 6.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.2 | 7.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.2 | 2.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.2 | 9.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.2 | 4.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.2 | 5.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.1 | 5.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.1 | 4.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 7.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.1 | 3.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.1 | 2.2 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.1 | 5.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.1 | 3.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.1 | 6.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 7.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.1 | 10.7 | GO:0045176 | apical protein localization(GO:0045176) |
1.0 | 10.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.0 | 12.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.0 | 3.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.0 | 3.0 | GO:0035106 | operant conditioning(GO:0035106) |
1.0 | 7.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.0 | 7.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 6.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.0 | 22.1 | GO:0007616 | long-term memory(GO:0007616) |
1.0 | 1.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.9 | 2.8 | GO:0030070 | insulin processing(GO:0030070) |
0.9 | 0.9 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.9 | 2.7 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.9 | 7.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.9 | 1.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.9 | 0.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 0.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.9 | 0.9 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.8 | 1.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.8 | 3.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 2.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.8 | 1.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 0.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.8 | 4.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.8 | 4.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 2.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.8 | 4.7 | GO:0015816 | glycine transport(GO:0015816) |
0.8 | 0.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.8 | 5.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.8 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.8 | 1.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.8 | 7.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 3.8 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.8 | 13.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.8 | 2.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.8 | 4.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 7.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.7 | 8.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.7 | 7.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 2.9 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.7 | 0.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.7 | 2.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 7.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.7 | 2.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 6.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.7 | 1.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 5.9 | GO:0048675 | axon extension(GO:0048675) |
0.7 | 1.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 26.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 2.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.6 | 1.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 51.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 4.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.6 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 3.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.6 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 2.5 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 2.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.6 | 13.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 0.6 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.6 | 1.8 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.6 | 1.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 1.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 4.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 1.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.6 | 2.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 1.2 | GO:0046959 | habituation(GO:0046959) |
0.6 | 2.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.6 | 0.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.6 | 4.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.6 | 1.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 12.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.6 | 2.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 2.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.6 | 13.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.6 | 1.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.6 | 3.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.6 | 1.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 3.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.6 | 1.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 1.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 0.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 3.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.5 | 6.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.5 | 1.1 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.5 | 3.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 1.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 1.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 13.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.5 | 3.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.5 | 4.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.5 | 1.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.5 | 4.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 38.5 | GO:0007612 | learning(GO:0007612) |
0.5 | 1.5 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.5 | 1.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 1.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 2.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 0.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 39.1 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.5 | 1.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.5 | 2.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 2.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.5 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 0.5 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.5 | 1.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 1.8 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 1.8 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 1.3 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.4 | 1.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.4 | 3.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 0.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 0.8 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 0.4 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 1.7 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 2.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.4 | 2.9 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.4 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 1.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 2.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 1.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.4 | 3.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 4.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 0.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 0.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 0.8 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 1.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 2.4 | GO:0001964 | startle response(GO:0001964) |
0.4 | 1.9 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.4 | 0.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 0.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 2.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 0.8 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 1.9 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 1.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 9.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 5.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 1.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 0.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 1.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 2.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.3 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.3 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 3.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.3 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 0.7 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 1.0 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.0 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.3 | 5.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 2.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.3 | 1.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.3 | 0.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 0.9 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 2.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 0.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 1.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 0.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 2.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 1.1 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 3.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 1.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.8 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 0.5 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.8 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.8 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.3 | 0.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.3 | 0.3 | GO:0007632 | visual behavior(GO:0007632) |
0.3 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.3 | 2.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 1.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 2.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 1.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 7.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.3 | 1.3 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 22.4 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.7 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.2 | 1.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 1.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.9 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.2 | 1.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 1.6 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.2 | 1.4 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.2 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 1.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.2 | 1.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.4 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.2 | 0.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.4 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.2 | 0.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.2 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.2 | 4.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.8 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 1.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 1.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.2 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.2 | 0.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.2 | GO:0071870 | cellular response to catecholamine stimulus(GO:0071870) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 1.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 2.7 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.2 | 0.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.2 | 0.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.5 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 4.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 2.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 1.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 1.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.2 | 0.7 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 1.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 4.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.7 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 3.0 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.3 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.7 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 10.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 0.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 5.5 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.2 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.6 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 1.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.6 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.6 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.8 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.6 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 1.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 2.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.3 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 1.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 0.1 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) regulation of the force of heart contraction by chemical signal(GO:0003057) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 2.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.6 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.1 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.1 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.7 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 1.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 2.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.3 | GO:2000667 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.1 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.1 | 0.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.9 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 1.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.2 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 1.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.7 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.6 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 1.0 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.5 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 3.4 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.1 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 1.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.7 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.8 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 2.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.1 | 0.3 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 1.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 1.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.3 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:1902590 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.4 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 3.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 1.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 3.9 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 1.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.4 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.1 | 0.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.1 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.9 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 2.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.1 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.1 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 2.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.0 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0003097 | renal water transport(GO:0003097) renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.2 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0032632 | interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) |
0.0 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0072608 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 1.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.0 | GO:0009209 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.0 | 0.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.1 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.0 | 0.4 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.3 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.5 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.1 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.0 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.3 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.0 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.0 | 0.0 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) actin filament branching(GO:0090135) negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.5 | 28.2 | GO:0043083 | synaptic cleft(GO:0043083) |
3.3 | 16.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.0 | 21.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
2.7 | 8.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.6 | 20.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.4 | 9.6 | GO:0044308 | axonal spine(GO:0044308) |
2.2 | 41.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.9 | 5.8 | GO:0072534 | perineuronal net(GO:0072534) |
1.8 | 12.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.7 | 10.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.7 | 16.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.6 | 82.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.6 | 19.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.5 | 12.4 | GO:0005883 | neurofilament(GO:0005883) |
1.5 | 3.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.5 | 12.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.5 | 14.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.5 | 21.9 | GO:0031527 | filopodium membrane(GO:0031527) |
1.4 | 2.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.4 | 9.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.3 | 9.2 | GO:0032584 | growth cone membrane(GO:0032584) |
1.2 | 13.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.2 | 39.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.2 | 3.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.2 | 11.6 | GO:0030673 | axolemma(GO:0030673) |
1.2 | 23.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.1 | 43.3 | GO:0043198 | dendritic shaft(GO:0043198) |
1.1 | 5.4 | GO:0097433 | dense body(GO:0097433) |
1.1 | 3.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 3.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.1 | 6.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 6.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.9 | 3.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.9 | 12.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.9 | 6.3 | GO:0071437 | invadopodium(GO:0071437) |
0.9 | 4.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 12.5 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 112.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 3.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.8 | 13.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.8 | 3.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 5.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 10.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 11.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 0.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 46.1 | GO:0030426 | growth cone(GO:0030426) |
0.6 | 28.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 33.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 1.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 9.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 4.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 1.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 10.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 2.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 5.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 4.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 1.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 5.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 8.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 26.6 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 4.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 0.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 4.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 39.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 13.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 1.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 2.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.1 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 11.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.1 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 1.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 3.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 5.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 8.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.5 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 3.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 1.7 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 0.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 2.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 4.0 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.6 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 9.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 3.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 2.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 24.3 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 2.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 2.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 1.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 4.7 | GO:0045202 | synapse(GO:0045202) |
0.0 | 6.2 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 1.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.0 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.1 | 24.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
6.9 | 13.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.6 | 26.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
5.3 | 15.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
4.6 | 23.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.0 | 23.7 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.9 | 20.1 | GO:0003680 | AT DNA binding(GO:0003680) |
2.8 | 22.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
2.8 | 8.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.5 | 9.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.5 | 12.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.4 | 19.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.3 | 7.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.2 | 17.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.2 | 6.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.0 | 12.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
2.0 | 10.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.0 | 17.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.9 | 5.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.8 | 11.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.8 | 5.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.8 | 7.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.6 | 10.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 33.4 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.4 | 15.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.4 | 5.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.4 | 16.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.3 | 25.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.3 | 2.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.3 | 6.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.3 | 21.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.2 | 13.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.2 | 4.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.2 | 3.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.2 | 22.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.2 | 4.7 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.1 | 4.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 8.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 4.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.0 | 20.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 10.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 22.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.9 | 2.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.9 | 2.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.9 | 2.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 4.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 1.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.8 | 7.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.8 | 5.0 | GO:0018498 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.8 | 3.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 2.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.8 | 5.5 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 3.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 3.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 8.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.8 | 3.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.7 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 8.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 2.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 18.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.7 | 2.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.7 | 2.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 24.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 4.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 3.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 2.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.7 | 3.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.7 | 2.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.7 | 2.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 2.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.7 | 2.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 2.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.6 | 3.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 1.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.6 | 6.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 1.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 4.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 2.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 4.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 7.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 2.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 2.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 5.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.6 | 2.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.6 | 1.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 9.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 1.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 1.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 5.9 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 2.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 1.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 8.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 15.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.5 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 8.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 1.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 6.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 7.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 1.3 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 2.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 30.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.4 | 4.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 10.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 5.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 8.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 5.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 1.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 6.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.9 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.4 | 4.4 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 4.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 10.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 1.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 5.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 1.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 1.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 2.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 2.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 3.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 2.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 1.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 3.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 6.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.3 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 2.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 6.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 0.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.3 | 2.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.8 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.9 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 1.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 4.1 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 2.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.3 | 2.5 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.7 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 2.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 4.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 2.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 22.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.9 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 0.9 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 3.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.6 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 4.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 1.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 1.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 2.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.8 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.1 | GO:0018650 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 5.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 0.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 4.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 4.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 3.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 5.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 2.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 2.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 1.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 1.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 6.8 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.2 | 0.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.9 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 2.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 3.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 1.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 3.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.6 | GO:0034845 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 5.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 4.6 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 20.7 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 14.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 2.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 1.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 1.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 4.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 14.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 6.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.5 | GO:0015464 | acetylcholine receptor activity(GO:0015464) G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.9 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 1.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 2.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 10.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.3 | GO:0052859 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 2.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 7.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.2 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.1 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 24.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.8 | 24.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.8 | 19.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.8 | 18.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 25.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 13.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 9.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 6.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 13.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 6.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 5.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 20.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 4.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 5.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 5.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 6.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 6.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 6.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 10.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 2.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 2.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 7.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 2.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 47.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.2 | 44.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.9 | 44.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.6 | 12.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.5 | 35.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.3 | 22.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 12.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.2 | 22.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.1 | 9.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.0 | 18.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.0 | 7.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.9 | 11.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 10.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 10.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 11.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.7 | 2.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 13.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.7 | 3.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 11.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 12.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 6.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 1.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 23.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.5 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 10.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 6.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 4.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 3.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 3.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 4.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 1.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 19.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 2.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 5.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 6.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 3.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 5.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 0.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 13.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.3 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 4.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 4.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 5.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 5.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 6.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 1.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 2.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 2.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 2.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 19.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 3.2 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 3.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |